“…Over the last 30 years MDTs have expanded to provide tumor streams for all common cancers (Walpole et al, 2019). Given the specialties of cancer MDTs (Lamb et al, 2011b;Pillay et al, 2016;Prades et al, 2015) evidence has underscored that each tumor specific MDT has their own unique challenges and impact on patient outcomes.…”